Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, May 24, 2024 | Back issues
Courthouse News Service Courthouse News Service

Mannatech CEO Fined for Deceptive Trade

DALLAS (CN) - Mannatech agreed to pay Texas consumers $4 million in restitution for falsely claiming its dietary supplements could cure Down syndrome, cancer and cystic fibrosis, Attorney General Greg Abbott said. Mannatech founder and CEO Samuel Caster must pay a $1 million civil penalty and cannot work for the company for five years under the agreement.

The settlement stems from deceptive trade practice charges the state brought in 2007.

"Under state and federal law, drug manufacturers cannot claim their products cure, treat, mitigate or prevent illness unless the product has been approved by the U.S. Food and Drug Administration as a drug," Abbott said. "Mannatech's products are supplements, not drugs, and they have not been approved as drugs by the (FDA)."

A self-proclaimed "global wellness solutions provider," Mannatech is based in Coppell, Texas and sells nutritional supplements in 10 countries.

Follow @cam_langford
Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.